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Synucleins are a family of homologous, predominantly neuronal proteins 
known for their involvement in synap-
tic transmission and neurodegeneration. 
γ-synuclein is predominantly local-
ized in axons and presynaptic terminals 
of selected populations of peripheral 
and central neurons but is also highly 
expressed in human white adipose tis-
sue (WAT) and increased in obesity. We 
have recently shown that γ-synuclein 
is nutritionally regulated in murine 
adipocytes while its loss protects mice 
from high fat diet (HFD)-induced obe-
sity and associated metabolic complica-
tions. This protection was coupled with 
increased adipocyte lipolysis, lipid oxida-
tion, and energy expenditure in HFD-fed 
γ-synuclein-null mutant compared with 
wild-type mice. Cellular studies suggest 
that relocalization of ATGL to the lipid 
droplet in γ-synuclein-deficient adipo-
cytes may contribute to increased lipoly-
sis in these cells. Loss of γ-synuclein in 
adipocytes also attenuates the assem-
bly of SNARE complexes, an impor-
tant component of lipid droplet fusion 
machinery, possibly due to reduced 
chaperoning of SNAP-23 to the assem-
bling SNARE complex by γ-synuclein. 
Together our data suggests that not only 
is γ-synuclein a novel regulator of lipid 
handling in adipocytes but also that the 
deficiency of this protein has a significant 
effect on whole body energy expenditure.
The synucleins (α-, β-, and γ-) are a family 
of highly homologous and chordate-spe-
cific proteins, with a pattern of overlapping 
expression throughout the nervous system. 
Whereas α- and β-synuclein are restricted 
to presynaptic terminals in the CNS, 
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γ-synuclein is abundant in the presynap-
tic terminals and axons of motor neurons 
and sensory neurons of the PNS where it is 
expressed from the earliest stages of neural 
development,1 although expression can also 
be found in certain populations of neurons 
localized in other regions of the CNS.2,3 
We have shown that in addition to neural 
tissues, γ-synuclein is highly expressed in 
murine white adipose tissue (WAT), with 
other groups reproducing this finding in 
humans and pigs, and that expression in 
humans is nutritionally regulated.4,5 We 
did not observe detectable expression of 
the other two synucleins in any depots of 
murine WAT suggesting that γ-synuclein 
is the major, if not the only, synuclein pro-
tein expressed in this tissue.
We demonstrated that in murine WAT 
γ-synuclein is expressed principally by 
the mature white adipocytes, and like in 
human WAT, is up and downregulated 
upon increased fat consumption in the diet 
and caloric restriction, respectively. These 
observations suggested a role of γ-synuclein 
in white adipocyte biology and stimulated 
us to pursue further in vitro and, par-
ticularly in vivo studies. The latter were 
facilitated by the availability of mice with 
constituent deletion of the γ-synuclein 
gene that had been previously produced in 
our laboratory.6 These animals were viable, 
fertile, and did not display any obvious neu-
rological or metabolic phenotype, although 
there were subtle alterations in certain neu-
ronal populations,6-9 including changes in 
lipid profiles and fatty acid patterns.10 In 
our recent publication in the Proceedings 
of the National Academy of Sciences11 we 
reported that knockout of γ-synuclein 
rescued mice from the increased adipos-
ity and metabolic derangements associated 
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types plays a role. Levels of γ-synuclein in 
liver and skeletal muscle are undetectable 
however one cannot entirely exclude the 
possibility that the protein is only pres-
ent in certain conditions and that its loss 
may alter lipid oxidation in these tissues. 
More likely to be important is the signifi-
cant neuronal expression of γ-synuclein. 
Hence its loss in relevant neuronal popula-
tions may contribute to some aspects of the 
phenotype we observed. On this note, two 
papers have revealed that hypothalamic 
expression of γ-synuclein is substantially 
downregulated in mice fasted for 48 h but 
restored to nearly ad libitum fed levels by 
leptin treatment in both the paraventricular 
and arcuate nucleus of the hypothalamus, 
a region well known for its modulation of 
downstream metabolic effects.18,19 Given 
that adipose tissue lipolysis is subject to sig-
nificant regulation by the nervous system, 
neuronal γ-synuclein could plausibly influ-
ence lipolytic rates in vivo. We therefore 
cannot at present exclude a role for an effect 
of γ-synuclein deficiency in the brain, nor 
any compensatory mechanisms activated 
in non-adipose tissues in response to global 
γ-synuclein knockout that could contrib-
ute to other aspects of the phenotype such 
as the increased energy expenditure or 
decreased hepatic steatosis. However, sev-
eral of the experiments described in our 
publication demonstrate that at least part 
of the observed effect on body lipid metab-
olism is caused by cell autonomous loss 
of γ-synuclein in adipose tissue. Clearly, 
as a future direction, this issue should be 
addressed and, hopefully resolved in stud-
ies of mice with conditional knockout of 
γ-synuclein specifically in adipocytes.
An intriguing link between the func-
tion of α-synuclein in neuronal synapses 
and γ-synuclein in adipocytes might also 
explain how γ-synuclein affects lipoly-
sis and the size of mature adipocytes in 
conditions of nutrient excess. Burre and 
colleagues have shown that in neuronal 
synapses, α-synuclein enhances neu-
rotransmitter exocytosis by regulation 
of synaptic vesicle fusion with the cell 
membrane via promoting the assembly 
of SNARE complexes from its subunits, 
namely vesicular SNARE protein vesicle-
associated membrane protein 2 (VAMP-2/
synaptobrevin) and two target membrane-
associated SNARE (tSNARE) proteins, 
BAT-like phenotype with this tissue adopt-
ing a more WAT like appearance and func-
tion.13 Indeed similar effects have also been 
observed in liver and macrophages.14,15 The 
beneficial metabolic effects we observe in 
γ-synuclein null mice may therefore result 
at least partly from increased supply of 
lipid substrates for oxidation from WAT 
or almost exclusively due to increased 
activation of oxidative capacity in the 
BAT itself. The high capacity of BAT for 
oxidising lipids and its ability to dissipate 
energy through uncoupled respiration 
has led to significant interest in increas-
ing the BAT:WAT ratio or inducing more 
BAT-like characteristics in WAT adipo-
cytes as a potential therapy for metabolic 
disease.16 Were this achievable it would 
evidently offer a route to dispose of excess 
lipids, reduce adiposity and protect other 
tissues from harmful ectopic lipid accu-
mulation. We did not find evidence either 
of increased mass of BAT nor browning 
of WAT depots, with the appearance of 
so-called “beige” or “brite” adipocytes, in 
γ-synuclein-deficient mice. However, we 
cannot exclude that this could also con-
tribute to the increased energy expenditure 
and lipid oxidation we reported. Clearly 
further studies are required to determine 
the relative contributions of WAT and 
BAT to the physiological effects we observe 
in this model.
The studies highlighted above regard-
ing TAG lipolysis imply that increasing 
this by increasing ATGL activity could be 
beneficial in metabolic disease. However, 
it should be noted that an opposite effect 
on WAT lipolysis, i.e., its downregula-
tion by decreasing the levels or activity of 
hormone sensitive lipase (HSL), have also 
been reported to ameliorate obesity asso-
ciated metabolic parameters, particularly 
insulin sensitivity.17 Due to compensatory 
mechanisms weight gain is also not exac-
erbated under these conditions. Overall 
this implies that the effects of altering 
lipolysis on metabolic health are complex 
and whether γ-synuclein offers a plausible 
means to influence this positively will 
depend on teasing apart the tissue specific 
effects and molecular details of where it 
acts in the process.
As γ-synuclein expression is not exclu-
sive to adipose tissue, it is also possible that 
loss of γ-synuclein expression in other cell 
with high fat diet feeding including hyper-
insulinemia and hepatic steatosis, the 
latter being strongly linked to hepatic 
insulin resistance and dysregulated glucose 
homeostasis. This rescue was associated 
with increased energy expenditure and 
lipid oxidation, and decreased adipocyte 
size. We also found that specifically re-
expressing γ-synuclein in the fat pads of 
null mutant mice using lentiviral vectors 
reverses the observed decrease in adipocyte 
size. Critically, this reversal was only seen in 
those adipocytes re-expressing γ-synuclein 
and not in non-transduced cells in the 
same depot, indicating that this aspect of 
the in vivo phenotype is cell-autonomous. 
Further investigations demonstrated that 
γ-synuclein loss caused increased expres-
sion of lipid oxidation markers in brown 
adipose tissue (BAT) as well as increased 
lipolysis in white adipocytes that may be 
explained by an observed increase of the 
lipase, ATGL. Interestingly, knockdown 
of γ-synuclein in differentiated 3T3-L1 
adipocytes resulted in a dramatic redistri-
bution of predominantly cytosolic ATGL 
enzyme to the lipid droplet surface, and 
that γ-synuclein and ATGL are capable of 
interacting, at least in vitro. This suggests 
that one function of γ-synuclein in mature 
adipocytes may be to sequester ATGL away 
from the lipid droplet when these cells are 
under basal conditions. As such the loss of 
γ-synuclein, while not actively stimulating 
lipolysis, facilitates the process by placing 
ATGL in close proximity to its substrate 
thereby enhancing lipolysis under any 
given condition.
We also found that γ-synuclein is 
expressed in brown adipocytes, although 
at a considerably lower level compared 
with that in white adipocytes. It is pos-
sible that γ-synuclein deficiency in BAT 
was at least partially responsible for the 
alterations seen in BAT lipid oxidation 
and overall increased energy expenditure 
in γ-synuclein null mice. Indeed stud-
ies of adipose selective overexpression of 
ATGL suggest that increased lipolysis 
in WAT and BAT increases lipid oxida-
tion and energy expenditure.12 It appears 
likely that this results at least partly from 
activation of oxidative gene expression in 
BAT downstream of products of lipolysis 
in this tissue. Conversely, adipose-spe-
cific ablation of ATGL results in a loss of 
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documented, including direct in vitro 
interaction of α-synuclein with PUFA.37,38 
There is also a large body of evidence sug-
gesting chaperone activity for all three 
synucleins.39-44 There is the highest degree 
of amino acid similarity between synucle-
ins within the first 85 residues, the region 
known to be responsible for interaction 
with lipids. However γ-synuclein differs 
considerably at the C-terminus from the 
other two family members.1,2,45 It appears 
that this diversion in C-terminal sequence 
confers some key differences in structure 
from the other two synucleins, and this is 
thought to mediate functional variations 
between the three proteins, with differ-
ences in γ-synuclein function expected to 
result from different protein–protein inter-
actions mediated by its C-terminus.46,47 It 
therefore seems feasible that each synuclein 
is able to bind certain lipids species not 
always in the same cell type, with their 
C-terminus responsible for the ability to 
bind different protein groups to facilitate 
various cellular outcomes.
We have shown that loss of γ-synuclein 
function in white adipocytes causes 
alterations in lipid handling, ultimately 
leading to changes in whole-body meta-
bolic outcome, and so it is possible that 
γ-synuclein plays a role in the develop-
ment of human obesity and related dis-
orders. Overall our initial study implies 
that inhibiting γ-synuclein expression or 
function might reduce adipose mass in 
obesity and reduce at least some aspects of 
associated metabolic disease. At present it 
is not clear whether insulin sensitivity per 
se is improved in mice lacking γ-synuclein 
although responses to insulin and glu-
cose challenges suggest that this is plau-
sible and worthy of future investigation. 
Similarly, future studies will be needed to 
reveal whether more subtly increasing or 
decreasing γ-synuclein in physiological or 
pathophysiological states might affect adi-
posity, insulin sensitivity, and lipid metab-
olism in rodents and in humans. This 
work has also shown that γ-synuclein is 
an important player in adipocyte biology, 
and has helped to highlight the potential 
importance of SNARE complex forma-
tion in appropriate adipocyte lipid storage. 
Although this is still an emerging concept 
in the field, it will be interesting to see if 
other modulators of SNARE complexes, 
γ-synuclein is acting pleiotropically to 
simultaneously increase lipid oxidation 
this may offset these potentially negative 
consequences of decreased lipid storage in 
WAT. It is also possible that the increased 
lipolysis we observe may partly reflect the 
increased availability of TAG, which has 
not been appropriately incorporated into 
the core of the lipid droplet. This TAG 
would then be subsequently hydrolysed, 
with this process requiring compensatory 
increases in ATGL protein levels (summa-
rized in Fig. 1). This inefficiency would 
be particularly apparent in situations of 
increased turnover, for example when 
WAT is exposed to increased dietary lip-
ids. This scenario would be similar to what 
was observed in α-synuclein-deficient neu-
rons, in the way that the prominent defect 
was seen during times of increased work 
load, in this case, upon increased synap-
tic firing. Overall our data suggest that 
both α-synuclein and γ-synuclein share 
the ability to potentiate SNARE-mediated 
fusion in physiological and/or environ-
mental conditions requiring increased 
efficiency of cellular mechanisms that 
depend on this fusion, the former impor-
tant for synaptic transmission in neuronal 
synapses and the latter important for lipid 
droplet maintenance and expansion in adi-
pocytes. At present only a few studies have 
assessed the importance of SNARE pro-
teins in adipocyte lipid droplet formation 
and turnover and further investigation 
both in vitro and in vivo will be required 
to clarify their importance and roles.
The wider involvement of synuclein 
family members in the upregulation of 
membrane vesicle fusion via SNARE com-
plexes is supported by findings over the 
past decade that describe the nature of 
the interactions of synucleins with lipid 
membranes as well as the possible chaper-
oning of other proteins. The link between 
synucleins and lipid biochemistry is well 
documented. α-synuclein has been shown 
to interact with phospholipid vesicles in 
vitro, with intracellular lipid droplets 
formed in cells loaded with lipids, and 
can accumulate at lipid rafts in cultured 
cells.30-34 Alterations in lipid metabolism 
have also been demonstrated in the brains 
of α-synuclein null mutant mice.35,36 
Links between synucleins and polyunsat-
urated fatty acids (PUFA) have also been 
syntaxin-1 and synaptosomal-associated 
protein 25 (SNAP-25).20 These com-
plexes play a pivotal role in synaptic vesicle 
docking and fusion pore formation at the 
plasma membrane, during the process of 
neurotransmitter release (reviewed in refs. 
21 and 22). In this paper, the function 
of α-synuclein as a promoter of SNARE 
complex assembly was suggested to be 
particularly important during periods of 
increased synaptic activity. Functional 
homologs of synaptic proteins, namely the 
vSNARE protein VAMP-4 and tSNARE 
proteins syntaxin-5 and SNAP-23, form 
SNARE complexes in adipocytes. These 
complexes are involved in fusion between 
neutral TAG packaged within amphipa-
thic lipoproteins and the lipid droplet 
phospholipid monolayer, the process that 
was suggested to underlie lipid accumu-
lation in the adipocyte and consequent 
increase in its size.23-26 More broadly, recent 
screens of genes affecting lipid droplet for-
mation, fusion and morphology in insect 
cells and yeast have revealed roles in these 
processes for several proteins involved 
in vesicle trafficking.27,28 In our publica-
tion we have shown that in conditions of 
increased lipid supply, i.e., in HFD-fed 
mice, the lack of γ-synuclein substantially 
attenuates assembly of SNARE complexes 
in adipocytes. We also demonstrated that 
γ-synuclein and the tSNARE SNAP-23 
colocalize in the cytosol of cells differen-
tiating into adipocytes in culture, and that 
this colocalization is partially lost upon 
oleate treatment. Findings that were not 
included in this publication also suggested 
that γ-synuclein and SNAP-23 can inter-
act in vitro, without γ-synuclein being a 
constituent of assembled SNARE com-
plexes. We hypothesize that γ-synuclein 
chaperones SNAP-23 to the forming 
SNARE complex during lipid partitioning 
in adipocytes. It is therefore possible that 
the decreased SNARE complex forma-
tion seen in γ-synuclein null adipocytes 
reduces TAG incorporation into the lipid 
droplet contributing to the decreased adi-
pocyte size, and overall, the decreased adi-
posity in mice. In itself, a decreased ability 
to appropriately store lipids would be likely 
to worsen rather than improve metabolic 
disease in the face of nutrient excess. This 
is most aptly illustrated in human syn-
dromes of lipodystrophy.29 However, if 
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to potentiate SNAre complex assembly may restrict the rate of lipid droplet fusion. Deficiency of γ-synuclein also increases the accumulation of AtGL 
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did not increase physical activity in mice but may alter neuronal inputs to peripheral tissues, particularly BAt and WAt, influencing whole body NeFA 
oxidation and energy expenditure (ee).
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